Annals of Oncology

in this issue:

in this issue
Ann Oncol 17: 355; doi:10.1093/annonc/mdl040
[Extract] [Full Text] [PDF] [Request Permissions]

editorials:

Luca Gianni

The cost of life: should it matter to doctors?
Ann Oncol 17: 357-358; doi:10.1093/annonc/mdl036
[Extract] [Full Text] [PDF] [Request Permissions]

E. Aitini and P. Aleotti

Breaking bad news in oncology: like a walk in the twilight?
Ann Oncol 17: 359-360; doi:10.1093/annonc/mdl012
[Extract] [Full Text] [PDF] [Request Permissions]

reviews:

R. Glynne-Jones, J. Dunst, and D. Sebag-Montefiore

The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?
Ann Oncol 17: 361-371; doi:10.1093/annonc/mdj052
[Abstract] [FREE Full Text] [PDF] [CME/CE] [Request Permissions]

I. Dimopoulou, A. Bamias, P. Lyberopoulos, and M. A. Dimopoulos

Pulmonary toxicity from novel antineoplastic agents
Annals of Oncology Advance Access published on November 16, 2005
Ann Oncol 17: 372-379; doi:10.1093/annonc/mdj057
[Abstract] [FREE Full Text] [PDF] [CME/CE] [Request Permissions]

original articles:

breast cancer:

M. Neyt, J. Albrecht, and V. Cocquyt

An economic evaluation of Herceptin^® in adjuvant setting: the Breast Cancer International Research Group 006 trial
Annals of Oncology Advance Access published on November 30, 2005
Ann Oncol 17: 381-390; doi:10.1093/annonc/mdj101
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C. T. M. Brekelmans, C. Seynaeve, M. Menke-Pluymers, H. T. Brüggenwirth, M. M. A. Tilanus-Linthorst, C. C. M. Bartels, M. Kriege, A. N. van Geel, C. M. G. Crepin, J. C. Blom, H. Meijers-Heijboer, and J. G. M. Klijn

Survival and prognostic factors in BRCA1-associated breast cancer
Annals of Oncology Advance Access published on December 1, 2005
Ann Oncol 17: 391-400; doi:10.1093/annonc/mdj095
[Abstract] [Full Text] [PDF] [Request Permissions]

H. T. Ford, R. C. Coombes, J.-C. Gazet, R. Gray, C. C. McConkey, R. Sutcliffe, J. Quilliam, and S. Lowndes

Long-term follow-up of a randomised trial designed to determine the need for irradiation following conservative surgery for the treatment of invasive breast cancer
Annals of Oncology Advance Access published on December 5, 2005
Ann Oncol 17: 401-408; doi:10.1093/annonc/mdj080
[Abstract] [Full Text] [PDF] [Request Permissions]

B. P. Coudert, L. Arnould, L. Moreau, P. Chollet, B. Weber, L. Vanlemmens, C. Moluçon, N. Tubiana, S. Causeret, J.-L. Misset, S. Feutray, D. Mery-Mignard, J. Garnier, and P. Fumoleau

Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial
Annals of Oncology Advance Access published on December 6, 2005
Ann Oncol 17: 409-414; doi:10.1093/annonc/mdj096
[Abstract] [Full Text] [PDF] [Request Permissions]

A. Scherwath, A. Mehnert, B. Schleimer, L. Schirmer, F. Fehlauer, R. Kreienberg, B. Metzner, E. Thiel, A. R. Zander, F. Schulz-Kindermann, and U. Koch

Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects
Annals of Oncology Advance Access published on December 15, 2005
Ann Oncol 17: 415-423; doi:10.1093/annonc/mdj108
[Abstract] [Full Text] [PDF] [Request Permissions]

L. Mercatali, V. Valenti, D. Calistri, S. Calpona, G. Rosti, S. Folli, M. Gaudio, G. L. Frassineti, D. Amadori, and E. Flamini

RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patients
Annals of Oncology Advance Access published on December 15, 2005
Ann Oncol 17: 424-428; doi:10.1093/annonc/mdj109
[Abstract] [Full Text] [PDF] [Request Permissions]

gynecologic tumors:

P. Viens, T. Petit, A. Yovine, P. Bougnoux, G. Deplanque, P.-H. Cottu, R. Delva, J.-P. Lotz, S. V. Belle, J.-M. Extra, and E. Cvitkovic

A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients
Ann Oncol 17: 429-436; doi:10.1093/annonc/mdj097
[Abstract] [Full Text] [PDF] [Request Permissions]

gastrointestinal tumors:

G. Chong, A. Bhatnagar, D. Cunningham, T. M. Cosgriff, P. G. Harper, W. Steward, J. Bridgewater, M. Moore, J. Cassidy, R. Coleman, F. Coxon, C. H. Redfern, J. J. Jones, R. Hawkins, D. Northfelt, S. Sreedharan, F. Valone, and J. Carmichael

Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer
Annals of Oncology Advance Access published on November 25, 2005
Ann Oncol 17: 437-442; doi:10.1093/annonc/mdj090
[Abstract] [Full Text] [PDF] [Request Permissions]

G. A. P. Hospers, M. Schaapveld, J. W. R. Nortier, J. Wils, A. van Bochove, R. S. de Jong, G. J. Creemers, Z. Erjavec, D. J. de Gooyer, P. H. Th. J. Slee, C. J. H. Gerrits, J. M. Smit, and N. H. Mulder

Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer
Ann Oncol 17: 443-449; doi:10.1093/annonc/mdj104
[Abstract] [Full Text] [PDF] [Request Permissions]

G. Folprecht, M. P. Lutz, P. Schöffski, T. Seufferlein, A. Nolting, P. Pollert, and C.-H. Köhne

Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma
Annals of Oncology Advance Access published on November 22, 2005
Ann Oncol 17: 450-456; doi:10.1093/annonc/mdj084
[Abstract] [Full Text] [PDF] [Request Permissions]

J. M. Blazeby, L. Wilson, C. Metcalfe, J. Nicklin, R. English, and J. L. Donovan

Analysis of clinical decision-making in multi-disciplinary cancer teams
Annals of Oncology Advance Access published on December 1, 2005
Ann Oncol 17: 457-460; doi:10.1093/annonc/mdj102
[Abstract] [Full Text] [PDF] [Request Permissions]

F. Panzuto, M. Di Fonzo, E. Iannicelli, R. Sciuto, C. L. Maini, G. Capurso, M. Milione, M. S. Cattaruzza, M. Falconi, V. David, V. Ziparo, P. Pederzoli, C. Bordi, and G. Delle Fave

Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma
Annals of Oncology Advance Access published on December 19, 2005
Ann Oncol 17: 461-466; doi:10.1093/annonc/mdj113
[Abstract] [Full Text] [PDF] [Request Permissions]

lung cancer:

C. Camps, B. Massuti, A. Jiménez, I. Maestu, R. García Gómez, D. Isla, J. L. González, D. Almenar, A. Blasco, R. Rosell, A. Carrato, N. Viñolas, N. Batista, C. García Girón, A. Galán, M. López, R. Blanco, M. Provencio, P. Diz, and E. Felip On behalf of the Spanish Lung Cancer Group

Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial
Annals of Oncology Advance Access published on December 21, 2005
Ann Oncol 17: 467-472; doi:10.1093/annonc/mdj115
[Abstract] [Full Text] [PDF] [Request Permissions]

A. Aupérin, C. Le Péchoux, J. P. Pignon, C. Koning, B. Jeremic, G. Clamon, L. Einhorn, D. Ball, M. G. Trovo, H. J. M. Groen, J. A. Bonner, T. Le Chevalier, and R. Arriagada On behalf of the Meta-Analysis of Cisplatin/carboplatin based Concomitant Chemotherapy in non-small cell Lung Cancer (MAC3-LC) Group

Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patients
Ann Oncol 17: 473-483; doi:10.1093/annonc/mdj117
[Abstract] [Full Text] [PDF] [Request Permissions]

hematologic malignancies:

B. Grünberger, W. Hauff, J. Lukas, S. Wöhrer, C. C. Zielinski, B. Streubel, A. Chott, and M. Raderer

‘Blind’ antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa
Ann Oncol 17: 484-487; doi:10.1093/annonc/mdj143
[Abstract] [Full Text] [PDF] [Request Permissions]

S. P. Treon, Z. R. Hunter, A. Aggarwal, E. P. Ewen, S. Masota, C. Lee, D. Ditzel Santos, E. Hatjiharissi, L. Xu, X. Leleu, O. Tournilhac, C. J. Patterson, R. Manning, A. R. Branagan, and C. C. Morton

Characterization of familial Waldenström's macroglobulinemia
Annals of Oncology Advance Access published on December 15, 2005
Ann Oncol 17: 488-494; doi:10.1093/annonc/mdj111
[Abstract] [Full Text] [PDF] [Request Permissions]

G. Martinelli, I. Iacobucci, G. Rosti, F. Pane, M. Amabile, F. Castagnetti, D. Cilloni, S. Soverini, N. Testoni, G. Specchia, S. Merante, A. Zaccaria, F. Frassoni, G. Saglio, M. Baccarani, and (Study writing committee for the GIMEMA Working Party on Chronic Myeloid Leukemia)

Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients
Annals of Oncology Advance Access published on January 10, 2006
Ann Oncol 17: 495-502; doi:10.1093/annonc/mdj106
[Abstract] [Full Text] [PDF] [Request Permissions]

sarcomas:

J. Stebbing, D. Mazhar, R. Lewis, C. Palmieri, E. Hatzimichael, M. Nelson, B. Gazzard, and M. Bower

The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi's sarcoma
Annals of Oncology Advance Access published on November 25, 2005
Ann Oncol 17: 503-506; doi:10.1093/annonc/mdj091
[Abstract] [Full Text] [PDF] [Request Permissions]

quality of life and supportive care:

Y. Lalami, M. Paesmans, F. Muanza, M. Barette, B. Plehiers, L. Dubreucq, A. Georgala, and J. Klastersky

Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factors? A retrospective analysis
Annals of Oncology Advance Access published on December 1, 2005
Ann Oncol 17: 507-514; doi:10.1093/annonc/mdj092
[Abstract] [Full Text] [PDF] [Request Permissions]

G. Iconomou, A. Viha, A. Koutras, I. Koukourikou, V. Mega, T. Makatsoris, A. Onyenadum, K. Assimakopoulos, A. G. Vagenakis, and H. P. Kalofonos

Impact of providing booklets about chemotherapy to newly presenting patients with cancer: a randomized controlled trial
Annals of Oncology Advance Access published on December 12, 2005
Ann Oncol 17: 515-520; doi:10.1093/annonc/mdj098
[Abstract] [Full Text] [PDF] [Request Permissions]

epidemiology:

C. Galeone, C. Pelucchi, F. Levi, E. Negri, R. Talamini, S. Franceschi, and C. La Vecchia

Folate intake and squamous-cell carcinoma of the oesophagus in Italian and Swiss men
Annals of Oncology Advance Access published on December 12, 2005
Ann Oncol 17: 521-525; doi:10.1093/annonc/mdj107
[Abstract] [Full Text] [PDF] [Request Permissions]

letters to the editor:

B. R. Bird, T. Elfiki, O. Tucker, and S. O'Reilly

Unilateral nail changes secondary to adriamycin: the protective effect of brachial plexopathy
Annals of Oncology Advance Access published on September 21, 2005
Ann Oncol 17: 527; doi:10.1093/annonc/mdj015
[Extract] [Full Text] [PDF] [Request Permissions]

B. Vincenzi, D. Santini, and G. Tonini

Lack of response of cetuximab plus oxaliplatin in advanced colorectal cancer patients resistant to both oxaliplatin and cetuximab plus irinotecan
Annals of Oncology Advance Access published on September 21, 2005
Ann Oncol 17: 527-528; doi:10.1093/annonc/mdj014
[Extract] [Full Text] [PDF] [Request Permissions]

G. Ferretti, E. Bria, A. Felici, P. Carlini, D. Giannarelli, M. Ciccarese, P. Papaldo, A. Fabi, A. Gelibter, and F. Cognetti

Catheter-associated thrombosis: thromboprophylaxis for cancer patients who carry factor V Leiden?
Annals of Oncology Advance Access published on October 26, 2005
Ann Oncol 17: 528-529; doi:10.1093/annonc/mdj021
[Extract] [Full Text] [PDF] [Request Permissions]

U. De Giorgi, S. Tana, and G. Rosti On behalf of the Italian Germ Cell Cancer Group (IGG)

Follow-up strategy of germ cell tumour patients
Annals of Oncology Advance Access published on October 18, 2005
Ann Oncol 17: 529-530; doi:10.1093/annonc/mdj026
[Extract] [Full Text] [PDF] [Request Permissions]

U. De Giorgi

Is high-dose chemotherapy based on carboplatin, a late dose-intensification of a cisplatin-based salvage chemotherapy in germ cell tumour patients?
Annals of Oncology Advance Access published on November 9, 2005
Ann Oncol 17: 530-531; doi:10.1093/annonc/mdj027
[Extract] [Full Text] [PDF] [Request Permissions]

W. Voigt, T. Kegel, G. Maher, K. Jordan, L. Müller, and H.-J. Schmoll

Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer
Annals of Oncology Advance Access published on October 18, 2005
Ann Oncol 17: 531-533; doi:10.1093/annonc/mdj028
[Extract] [Full Text] [PDF] [Request Permissions]

U. Tirelli, M. Balzarotti, L. Uziel, A. J. M. Ferreri, A. Santoro, and M. Spina On behalf of the G.O.L. (Gruppo Oncoematologico Linfomi) cooperative study group

Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas
Annals of Oncology Advance Access published on November 15, 2005
Ann Oncol 17: 533; doi:10.1093/annonc/mdj045
[Extract] [Full Text] [PDF] [Request Permissions]

corrigendum:

H. Oettle, D. Richards, R. K. Ramanathan, J. L. van Laethem, M. Peeters, M. Fuchs, A. Zimmermann, W. John, D. Von Hoff, M. Arning, and H. L. Kindler

A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer. Ann Oncol 2005; 16: 1639–1645
Ann Oncol 17: 535; doi:10.1093/annonc/mdl032
[Extract] [Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.